Home / Business and Economy / Aroa Biosurgery's Shareholder Landscape: Individuals Dominate, Institutions Gain Ground
Aroa Biosurgery's Shareholder Landscape: Individuals Dominate, Institutions Gain Ground
16 Nov
Summary
- Individual investors hold 42% of Aroa Biosurgery shares
- Institutional investors own 32% of the company
- CEO Brian Ward is the largest shareholder with 9.6% stake
According to the latest analysis as of November 16, 2025, individual investors currently hold the largest stake in Aroa Biosurgery, owning around 42% of the company's shares. In contrast, institutional investors have a 32% ownership in the firm.
The analysis also reveals that the company's CEO, Brian Ward, is the single largest shareholder, holding 9.6% of Aroa Biosurgery's outstanding shares. The second and third largest shareholders are Acorn Capital Limited and Harbour Asset Management Limited, each with a 7.6% stake.
Interestingly, the top 11 shareholders control a combined 51% of the company, suggesting that no individual investor or group has a majority interest in Aroa Biosurgery. This diverse ownership structure indicates that the company has attracted a range of investors, both institutional and individual, who see potential in its future growth and performance.
